NeoGenomics to Present Multiple Abstracts Showcasing New Research at AACR Annual Meeting 2026
NeoGenomics to Report First Quarter 2026 Financial Results on April 28, 2026
NeoGenomics’ PanTracer LBx Receives Medicare Coverage, Expanding Access to Comprehensive Liquid Biopsy Profiling
Annual report [Section 13 and 15(d), not S-K Item 405]
Current report
Definitive proxy statements
View and filter by group or type
